About this trial
This study looks at how common certain antibiotic-resistant bacteria (called extended-spectrum beta-lactamase-producing Enterobacteriaceae, or E-BLSE) are in pregnant women who experience premature breaking of their water before full term. The goal is to understand how often these bacteria are found, how long they stay, and what factors increase the risk of carrying them. This information will help doctors choose the best antibiotics to protect both the mother and baby from infections during and after pregnancy. The study follows women from the time of their membrane rupture until delivery, collecting samples to track the bacteria over time.
Eligibility criteria
Qualifiers
Pregnant women aged over 18 years
Diagnosed with premature rupture of membranes before term (between 23 weeks + 0 days and 36 weeks + 6 days of gestation)
Managed in one of the participating maternity hospitals
Disqualifiers
No available microbiological sample
Minors or women under legal guardianship (curatorship, tutelage, or judicial protection)
Women who refuse the use of their clinical data for research purposes at admission or within one month after receiving the information document
Trial design
Treatments tested in this trial
- Not listed